Fmr LLC Aldeyra Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 9,147 shares of ALDX stock, worth $53,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,147

Previous 7,668 19.29%

Holding current value

$53,692

Previous $25,000 20.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.25 - $4.72 $4,806 - $6,980	1,479 Added 19.29%	9,147 $30,000
Q1 2024 May 13, 2024	BUY	$2.77 - $4.22 $2,938 - $4,477	1,061 Added 16.06%	7,668 $25,000
Q4 2023 Feb 13, 2024	BUY	$1.47 - $6.06 $2,429 - $10,017	1,653 Added 33.37%	6,607 $23,000
Q3 2023 Nov 13, 2023	SELL	$6.11 - $8.16 $4.13 Million - $5.52 Million	-676,304 Reduced 99.27%	4,954 $33,000
Q2 2023 Aug 11, 2023	SELL	$7.11 - $11.89 $764,545 - $1.28 Million	-107,531 Reduced 13.63%	681,258 $5.72 Million
Q1 2023 May 11, 2023	SELL	$5.77 - $9.93 $1.02 Million - $1.76 Million	-177,287 Reduced 18.35%	788,789 $7.83 Million
Q4 2022 Feb 13, 2023	SELL	$5.08 - $7.09 $428,665 - $598,275	-84,383 Reduced 8.03%	966,076 $6.72 Million
Q3 2022 Nov 10, 2022	BUY	$3.8 - $7.74 $1.43 Million - $2.91 Million	375,875 Added 55.72%	1,050,459 $5.61 Million
Q2 2022 Aug 12, 2022	BUY	$2.43 - $4.85 $1.63 Million - $3.25 Million	670,651 Added 17051.89%	674,584 $2.69 Million
Q1 2022 May 13, 2022	BUY	$3.25 - $5.17 $12,460 - $19,821	3,834 Added 3872.73%	3,933 $17,000
Q4 2021 Feb 14, 2022	SELL	$3.5 - $9.63 $4.21 Million - $11.6 Million	-1,201,911 Reduced 99.99%	99 $0
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $682 - $972	-86 Reduced 0.01%	1,202,010 $10.6 Million
Q2 2021 Aug 13, 2021	BUY	$10.44 - $14.85 $12.5 Million - $17.9 Million	1,202,096 New	1,202,096 $13.6 Million

Others Institutions Holding ALDX

# of Institutions

106

Shares Held

35.1M

Call Options Held

153K

Put Options Held

83.9K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $342M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account